tradingkey.logo

Retractable Technologies Inc

RVP
0.650USD
+0.003+0.51%
Close 02/06, 16:00ETQuotes delayed by 15 min
19.46MMarket Cap
LossP/E TTM

Retractable Technologies Inc

0.650
+0.003+0.51%

More Details of Retractable Technologies Inc Company

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Retractable Technologies Inc Info

Ticker SymbolRVP
Company nameRetractable Technologies Inc
IPO dateMay 04, 2001
CEOShaw (Thomas J)
Number of employees221
Security typeOrdinary Share
Fiscal year-endMay 04
Address511 Lobo Lane
CityLITTLE ELM
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code75068-0009
Phone19722941010
Websitehttps://retractable.com/
Ticker SymbolRVP
IPO dateMay 04, 2001
CEOShaw (Thomas J)

Company Executives of Retractable Technologies Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+13331.00%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--
Mr. John W. Fort, III
Mr. John W. Fort, III
Chief Financial Officer, Vice President, Treasurer, Director
Chief Financial Officer, Vice President, Treasurer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+13331.00%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Syringes
5.85M
57.98%
EasyPoint Needles
3.85M
38.21%
Blood Cllection Products
372.75K
3.70%
Other Products
11.46K
0.11%
By RegionUSD
Name
Revenue
Proportion
United States
9.19M
91.09%
North and South America(excluding U.S)
549.80K
5.45%
Other International
348.35K
3.45%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Syringes
5.85M
57.98%
EasyPoint Needles
3.85M
38.21%
Blood Cllection Products
372.75K
3.70%
Other Products
11.46K
0.11%

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Shaw (Thomas J)
54.55%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.25%
Renaissance Technologies LLC
1.43%
Eversept Partners, LP
1.21%
Other
37.68%
Shareholders
Shareholders
Proportion
Shaw (Thomas J)
54.55%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.25%
Renaissance Technologies LLC
1.43%
Eversept Partners, LP
1.21%
Other
37.68%
Shareholder Types
Shareholders
Proportion
Individual Investor
58.12%
Investment Advisor
4.12%
Hedge Fund
3.07%
Investment Advisor/Hedge Fund
0.92%
Venture Capital
0.05%
Research Firm
0.04%
Other
33.67%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
62
2.46M
8.23%
+140.22K
2025Q3
63
2.10M
7.00%
-941.15K
2025Q2
76
19.64M
65.62%
-749.70K
2025Q1
78
19.36M
64.67%
-761.97K
2024Q4
83
19.19M
64.11%
-1.01M
2024Q3
90
19.53M
65.24%
-827.36K
2024Q2
106
19.17M
64.04%
-1.44M
2024Q1
142
19.01M
63.51%
-2.11M
2023Q4
155
19.23M
64.23%
-1.87M
2023Q3
169
20.44M
68.26%
-2.39M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Shaw (Thomas J)
16.33M
54.55%
+13.33K
+0.08%
Nov 14, 2025
Larios Michele Mitchell
861.00K
2.88%
--
--
Mar 10, 2025
The Vanguard Group, Inc.
672.81K
2.25%
-1.00K
-0.15%
Sep 30, 2025
Renaissance Technologies LLC
427.56K
1.43%
+79.16K
+22.72%
Sep 30, 2025
Eversept Partners, LP
363.31K
1.21%
+363.31K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
241.12K
0.81%
-4.03K
-1.64%
Sep 30, 2025
Geode Capital Management, L.L.C.
128.11K
0.43%
--
--
Sep 30, 2025
Bridgeway Capital Management, LLC
88.54K
0.3%
-67.09K
-43.11%
Sep 30, 2025
Laterza (Marco)
85.00K
0.28%
--
--
Mar 10, 2025
Bigby (Walter O Jr)
80.00K
0.27%
--
--
Mar 10, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI